Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 24100378)

1.

Protein-bound polysaccharide-K augments the anticancer effect of fluoropyrimidine derivatives possibly by lowering dihydropyrimidine dehydrogenase expression in gastrointestinal cancers.

Mekata E, Murata S, Sonoda H, Shimizu T, Umeda T, Shiomi H, Naka S, Yamamoto H, Abe H, Edamatsu T, Fujieda A, Fujioka M, Wada T, Tani T.

Oncol Rep. 2013 Dec;30(6):2845-51. doi: 10.3892/or.2013.2788. Epub 2013 Oct 4.

PMID:
24100378
2.

[Prediction of sensitivity to 5-fluorouracil (5-fu) by metabolic and target enzyme activities in colon cancer].

Yamada T, Tanaka N, Yokoi K, Ishikawa N, Seya T, Horiba K, Kanazawa Y, Shirakawa T, Ohkawa K, Kudoh H, Koizumi M, Yoshioka M, Shinji S, Yamashita K, Tajiri T.

Gan To Kagaku Ryoho. 2006 Nov;33(11):1603-9. Japanese.

PMID:
17108726
3.

Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.

Okumura K, Shiomi H, Mekata E, Kaizuka M, Endo Y, Kurumi Y, Tani T.

Oncol Rep. 2006 Apr;15(4):875-82.

PMID:
16525674
6.

Alteration of dihydropyrimidine dehydrogenase expression by IFN-alpha affects the antiproliferative effects of 5-fluorouracil in human hepatocellular carcinoma cells.

Oie S, Ono M, Fukushima H, Hosoi F, Yano H, Maruyama Y, Kojiro M, Terada T, Hirano K, Kuwano M, Yamada Y.

Mol Cancer Ther. 2007 Aug;6(8):2310-8.

7.

Influence of chemotherapeutic agents and cytokines on the expression of 5-fluorouracil-associated enzymes in human colon cancer cell lines.

Miyazaki K, Shibahara T, Sato D, Uchida K, Suzuki H, Matsui H, Yanaka A, Nakahara A, Matsuzaki Y.

J Gastroenterol. 2006 Feb;41(2):140-50.

PMID:
16568373
8.

Role of dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine against non-small cell lung cancer--in correlation with the tumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase.

Inoue K, Takao M, Watanabe F, Tarukawa T, Shimamoto A, Kaneda M, Sakai T, Fukushima M, Shimpo H, Yada I.

Lung Cancer. 2005 Jul;49(1):47-54.

PMID:
15949589
9.

Predictive markers of capecitabine sensitivity identified from the expression profile of pyrimidine nucleoside-metabolizing enzymes.

Yasuno H, Kurasawa M, Yanagisawa M, Sato Y, Harada N, Mori K.

Oncol Rep. 2013 Feb;29(2):451-8. doi: 10.3892/or.2012.2149. Epub 2012 Nov 27.

PMID:
23229803
10.

Correlations between antitumor activities of fluoropyrimidines and DPD activity in lung tumor xenografts.

Takechi T, Okabe H, Ikeda K, Fujioka A, Nakagawa F, Ohshimo H, Kitazato K, Fukushima M.

Oncol Rep. 2005 Jul;14(1):33-9.

PMID:
15944764
12.

The role of thymidylate synthase and dihydropyrimidine dehydrogenase in resistance to 5-fluorouracil in human lung cancer cells.

Oguri T, Achiwa H, Bessho Y, Muramatsu H, Maeda H, Niimi T, Sato S, Ueda R.

Lung Cancer. 2005 Sep;49(3):345-51.

PMID:
15993511
13.

Low-dose cisplatin and 5-fluorouracil in combination can repress increased gene expression of cellular resistance determinants to themselves.

Nishiyama M, Yamamoto W, Park JS, Okamoto R, Hanaoka H, Takano H, Saito N, Matsukawa M, Shirasaka T, Kurihara M.

Clin Cancer Res. 1999 Sep;5(9):2620-8.

14.

Synergistic antitumor effect of combined 5-fluorouracil (5-FU) with 5-chloro-2,4-dihydroxypyridine on 5-FU-resistant gastric cancer cells: possible role of a dihydropyrimidine dehydrogenase-independent mechanism.

Sasaki E, Tominaga K, Kuwamura H, Watanabe T, Fujiwara Y, Oshitani N, Higuchi K, Arakawa T.

J Gastroenterol. 2007 Oct;42(10):816-22. Epub 2007 Oct 15.

PMID:
17940834
15.

Thymidylate synthetase (TS) genotype and TS/dihydropyrimidine dehydrogenase mRNA level as an indicator in determining chemosensitivity to 5-fluorouracil in advanced gastric carcinoma.

Toriumi F, Kubota T, Saikawa Y, Yoshida M, Otani Y, Watanabe M, Kumai K, Kitajima M.

Anticancer Res. 2004 Jul-Aug;24(4):2455-63.

16.

Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.

Kornmann M, Schwabe W, Sander S, Kron M, Sträter J, Polat S, Kettner E, Weiser HF, Baumann W, Schramm H, Häusler P, Ott K, Behnke D, Staib L, Beger HG, Link KH.

Clin Cancer Res. 2003 Sep 15;9(11):4116-24.

17.

Efficacy of laser capture microdissection plus RT-PCR technique in analyzing gene expression levels in human gastric cancer and colon cancer.

Makino H, Uetake H, Danenberg K, Danenberg PV, Sugihara K.

BMC Cancer. 2008 Jul 25;8:210. doi: 10.1186/1471-2407-8-210.

18.

Relationship between expression of 5-fluorouracil metabolic enzymes and 5-fluorouracil sensitivity in esophageal carcinoma cell lines.

Ando T, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Sugito N, Mori R, Ogawa R, Katada T, Fujii Y.

Dis Esophagus. 2008;21(1):15-20. doi: 10.1111/j.1442-2050.2007.00700.x.

PMID:
18197934
19.

Expression of thymidylate synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, and orotate phosphoribosyl transferase in prostate cancer.

Miyoshi Y, Uemura H, Ishiguro H, Kitamura H, Nomura N, Danenberg PV, Kubota Y.

Prostate Cancer Prostatic Dis. 2005;8(3):260-5.

PMID:
15999119
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk